Graybug Vision, Inc. said that Thomas S. Templeman, PhD, has joined the company as Chief Operating Officer. In this new position, Dr. Templeman reports to Graybug Vision Chief Executive Officer Jeffrey L. Cleland, PhD, and will lead process development, manufacturing, quality and program management. Dr. Templeman joins Graybug Vision from Medivation (acquired by Pfizer in late 2016), where he was Senior Vice President Pharmaceutical Operations and Quality.